They incessantly secrete a diverse array of immunosuppressive factors, such as transforming growth factor-β (TGF-β) and interleukin-10 (IL-10), further suppressing the activity and function of immune cells, rendering it arduous for immunotherapy to fully exert its efficacious anti-tumor effect (4–6). The gene discussed is IL10; the disease is neoplasm.